Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

CorMedix Inc.

NASDAQ: CRMD · Life Sciences · 8 alerts · CIK 1410098

Share price
$4.82Close, Nov 16
Market cap
$383M
Shares outstanding
79.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CorMedix Inc. filings on SEC EDGAR ↗

7:40 AM ET 8-K
Business Update

CorMedix Business Update

CorMedix provided a business update reporting a cash position of approximately $355 million as of September 30, 2026, and reaffirmed its full-year 2026 revenue guidance. The company also addressed the CMS 2027 ESRD PPS final rule regarding DefenCath reimbursement, projecting that the average 2027 Add-on rate will be more than double the current rate.

8:00 AM ET 8-K
Business Update

CorMedix Business Update

CorMedix announced that the FDA has accepted for filing a supplemental New Drug Application (sNDA) for REZZAYO (rezafungin for injection) for the prophylaxis of invasive fungal disease. The FDA granted Priority Review for the application, which is supported by positive Phase III ReSPECT study data, and set a PDUFA target action date in Q1 2027.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.